Globus Medical, Inc.

Total Valuation

Globus Medical, Inc. carries a market capitalization of 11.58B, placing it among publicly traded companies globally. Its enterprise value stands at 10.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Globus Medical, Inc. currently has 134.61M shares outstanding.

Valuation Ratios

Globus Medical, Inc. trades at a trailing price-to-earnings ratio of 19.90. The price-to-sales ratio is 3.39, and the price-to-book ratio stands at 2.23.

Enterprise Valuation

On an enterprise value basis, Globus Medical, Inc. trades at an EV/EBITDA multiple of 10.64 and an EV/FCF ratio of 9.49. The EV/Sales ratio of 3.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.07 provides insight into valuation relative to core operating earnings.

Financial Position

Globus Medical, Inc. maintains a current ratio of 4.62, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Globus Medical, Inc. posts a return on equity of 11.81 and a return on invested capital of 11.75.

Taxes

Over the trailing twelve months, Globus Medical, Inc. has paid 124.69M in income taxes, reflecting an effective tax rate of 18.89.

Stock Price Statistics

Globus Medical, Inc.'s stock has gained approximately 41.81938% over the past 52 weeks. The 50-day moving average sits at 80.00, while the 200-day moving average is 85.08.

Income Statement

Over the trailing twelve months, Globus Medical, Inc. generated 3.14B in revenue and converted that into 535.43M in net income, yielding earnings per share of 3.91. EBITDA reached 953.68M, while operating income came in at 673.76M.

Balance Sheet

Globus Medical, Inc. holds 595.14M in cash and equivalents against 111.19M in total debt, resulting in a net debt position of -507.74M. Total book value stands at 4.77B, with working capital of 1.74B providing operational flexibility.

Cash Flow

Globus Medical, Inc. produced 910.39M in operating cash flow over the past twelve months. After subtracting -159.54M in capital expenditures, free cash flow totaled 750.84M - equivalent to 5.57 per share.

Margins

Globus Medical, Inc. operates with a gross margin of 68.55, reflecting its pricing power and cost economics. The operating margin of 21.42 and net profit margin of 17.03 provide insight into operational efficiency.

Dividends & Yields

Scores

Globus Medical, Inc. posts an Altman Z-Score of 11.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.